A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors

Clinical trial NCT04513223 · COMPLETED

Trial details

NCT number: NCT04513223
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Colorectal Cancer

Start date: 2021-03-30
Primary completion: 2025-03-28
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.